Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Illaro Uranga, A."'
Autor:
Ramón Morillo-Verdugo, Tamara Aguilar Pérez, Mercedes Gimeno-Gracia, Carmen Rodríguez-González, María de las Aguas Robustillo-Cortes, Aitziber Illaro Uranga, Alicia Lázaro López, Angels Andreu Crespo, Aránzazu Linares Alarcón, Beatriz Proy Vega, Belén López García, Carlos Seguí Solanes, Carolina Aguilar Guisado, Elena Cárdaba García, Emilio Molina Cuadrado, Emilio Monte Boquet, Encarna Abad Lecha, Esther Vicente Escrig, Gabriel Mercadal Orfila, Herminia Navarro Aznárez, Inmaculada Nacle López, Irene Cañamares Orbis, Jara Gallardo Anciano, Javier Casas Arrate, Javier Sánchez-Rubio Ferrández, Joaquín Ignacio Serrano López, José Alberto Peña Pedrosa, Jose Sebastián Roldan González, Luis Carlos Fernández Lisón, Luis Margusino Framinan, Luis Ortega Valín, Maite Martin, Manuel Vélez, María Ángeles Andreu Crespo, Maria Carmen Rosado Maria, María García Coronel, Maria Jose Huertas Fernández, Mercedes Manzano García, Noelia Garrido Peña, Oihana Mora Atorrasagasti, Patricia Sanmartin Fenollera, Pilar Díaz Ruíz, Ramón San Miguel Elcano, Raquel Fresquet Molina, Vera Áreas del Águila, Dr Elena Rebollo-Gómez, Dr Vanessa Marfil
Publikováno v:
The Annals of pharmacotherapy. 57(2)
Background People living with human immunodeficiency virus (HIV) require specific pharmaceutical care (PC). Although the 2017 Capacity-Motivation-Opportunity (CMO) PC model allows a multidisciplinary approach that focuses on patient needs, it is too
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6db55a4e1fc31086547812ddd86b5bdb
https://pubmed.ncbi.nlm.nih.gov/35707861
https://pubmed.ncbi.nlm.nih.gov/35707861
Autor:
Morillo Verdugo, R., Martín Conde, M.T., Valverde Merino, M.P., Illaro Uranga, A., Ventura Cerdá, J.M., Serrano López de las Hazas, J., Plata Paniagua, S., Ibarra Barrueta, O., Moriel Sanchez, C., Ortega Valín, L., Fernández Palacín, A., Almeida González, C.
Publikováno v:
In Farmacia Hospitalaria September-October 2012 36(5):343-350
Autor:
Olatz, Ibarra-Barrueta, Oihana, Mora-Atorrasagasti, María José, Legarreta, Aitziber, Illaro-Uranga, Ramón, Morillo-Verdugo
Publikováno v:
Farmacia Hospitalaria, Vol 43, Iss 3, Pp 87-93 (2019)
The primary endpoint is to validate the HIV Symptoms Index Questionnaire in a Spanish population, in terms of comprehension and acceptability. The secondary endpoints are to describe symptoms reported by patients, tolerance, and quality of life.The p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::cdb390128275d239b12ff90ba2d221b4
http://www.aulamedica.es/fh/pdf/11127.pdf
http://www.aulamedica.es/fh/pdf/11127.pdf
Autor:
Sánchez Gundín,J, Illaro Uranga,A, Llorente Serrano,M, Martínez Torrón,A, Gómez Gómez,D, Valero Domínguez,M
Publikováno v:
Revista de la OFIL v.31 n.3 2021
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Resumen Introducción: Evaluar efectividad y seguridad de evolocumab en la reducción de los datos analíticos referentes al colesterol. Material y métodos: Estudio observacional, descriptivo y retrospectivo de pacientes tratados con evolocumab dura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::e64811f8edea5acaf1a9731524a296f1
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-714X2021000300263
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-714X2021000300263
Autor:
L. Pérez-Periáñez Orillo, R. M. González Franco, A Illaro Uranga, M Valero Domínguez, CM Valencia Soto, P Del Rio Ortega, J Casanova Vázquez, CA Alonso Peralta, B Rogado Vegas, I Aragon Gracia, M Rioja Carrera
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Isavuconazole (ISA) is an authorised antifungal for the treatment of invasive fungal infection (IFI) by Aspergillus in adult patients in which amphotericin B is not appropriate. Aim and objectives To assess the conditions of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0350f9435d1baf3c58b3657353d87a5
https://doi.org/10.1136/ejhpharm-2020-eahpconf.156
https://doi.org/10.1136/ejhpharm-2020-eahpconf.156
Autor:
Ibarra-Barrueta, Olatz, Mora-Atorrasagasti, Oihana, Aguirre, Urko, Legarreta, María José, Illaro-Uranga, Aitziber, Morillo-Verdugo, Ramón
Publikováno v:
Farmacia Hospitalaria, Volume: 43, Issue: 3, Pages: 87-93, Published: 14 OCT 2019
Objective The primary endpoint is to validate the HIV Symptoms Index Questionnaire in a Spanish population, in terms of comprehension and acceptability. The secondary endpoints are to describe symptoms reported by patients, tolerance, and quality of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______624::af3796c7b294ada9bd6126f4d9493ccb
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432019000300004&lng=en&tlng=en
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432019000300004&lng=en&tlng=en
Autor:
E Martinez de Ilarduya Bolado, M Oro Fernández, L Senra Afonso, H Cristóbal Gutiérrez, A Illaro Uranga, MA Martín Vega, M Valero Domínguez, JF Mayorga Pérez, C Garay Sarría, N Lizama Gómez
Publikováno v:
Clinical pharmacy.
Background Ustekinumab is a human monoclonal antibody against interleukin 12 and interleukin 23. Its use in inflammatory bowel disease (IBD) is little known. Purpose To evaluate the effectiveness and safety of ustekinumab in adults with moderate to s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa94ef3e088b0bc6b6bfec20aa452374
https://doi.org/10.1136/ejhpharm-2017-000640.200
https://doi.org/10.1136/ejhpharm-2017-000640.200
Autor:
Morillo-Verdugo, R., Jiménez-Galán, R., Ibarra Barrueta, O., Martín Conde, M., Margusino Framinan, L., Illaro Uranga, A.
Publikováno v:
Farmacia Hospitalaria, Vol 38, Iss 2, Pp 89-99 (2014)
Farmacia Hospitalaria, Volume: 38, Issue: 2, Pages: 89-99, Published: APR 2014
Farmacia Hospitalaria, Volume: 38, Issue: 2, Pages: 89-99, Published: APR 2014
Objetivos: Describir la estructura, proceso y resultados con la que se lleva a cabo la actividad asistencial, docente e investigadora en torno a la Atención Farmacéutica (AF) al paciente VIH en los hospitales españoles. Material y métodos: Estudi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::62e16ef9baea45b2b74dcd93a6654abf
http://www.aulamedica.es/fh/pdf/1113.pdf
http://www.aulamedica.es/fh/pdf/1113.pdf
Autor:
Paula Pérez-Puente, Aitziber Illaro-Uranga, Luis Margusino-Framiñán, María Ángeles Porta-Sánchez, Jesús Mayorga-Pérez, Patricia Sanmartín-Fenollera, Inmaculada Ramírez-Alapont, Laura Lorente-Fernández, Emilio Monte-Boquet, Javier García-Fernández, Miguel Ángel Conesa-Muñoz, Ana García-Monsalve, Isabel Moya-Carmona, Ignacio Cardona-Pascual, Elena Victoria Tortajada-Esteban, José Ramón Vizoso-Hermida, Sheila Mora-García, María Fernández-Pacheco, María Olatz Ibarra-Barrueta
Publikováno v:
European Journal of Hospital Pharmacy. 20:20-25
Objective To assess unmet needs at hospital pharmacies and treatment adherence of patients with multiple sclerosis (MS) treated with disease-modifying therapies (DMTs). Methods A non-interventional and multicentre study involving 24 pharmacies that i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c000a488c8ad320ee4821a6bec83e91f
https://doi.org/10.1136/ejhpharm-2012-000183
https://doi.org/10.1136/ejhpharm-2012-000183
Autor:
R Morillo Verdugo, L. Ortega Valín, M.ª T. Martín Conde, C Moriel Sánchez, J.I. Serrano López de las Hazas, C. Almeida González, M. P. Valverde Merino, S. Plata Paniagua, J.M. Ventura Cerdá, A. Fernández Palacín, A. Illaro Uranga, O. Ibarra Barrueta
Publikováno v:
Farmacia Hospitalaria. 36:343-350
Objective: To develop and validate a prediction model for the detection of drug-related problems (DRP) in patients on antiretroviral treatment during their regular monitoring in Pharmaceutical Care Clinics before dispensing drugs. Mehod: Open multice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cacb950e85db560f6dfde86518417b8
https://doi.org/10.1016/j.farma.2011.11.003
https://doi.org/10.1016/j.farma.2011.11.003